Bogdan Popescu
Overview
Explore the profile of Bogdan Popescu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
450
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tomaselli M, Springhetti P, Benfari G, Penso M, Clement A, Pilan M, et al.
Eur Heart J Cardiovasc Imaging
. 2025 Jan;
PMID: 39874256
Aims: This study evaluates whether multi-chamber myocardial deformation analysis using speckle tracking echocardiography (STE) can enhance validated current staging systems and improve risk stratification for patients with moderate-to-severe aortic stenosis...
2.
Rujan S, Bertesteanu S, Grigore R, Popescu B, Condeescu-Cojocarita M, Alexandru N, et al.
J Pers Med
. 2024 Mar;
14(3).
PMID: 38541025
Introduction: Oropharyngeal cancer requires a comprehensive evaluation of treatment options, including surgery, radiation therapy, and chemotherapy. It is crucial to customize these treatments based on the stage of the tumor...
3.
Dragomir M, Calugaru O, Popescu B, Jardan C, Jardan D, Popescu M, et al.
Cancers (Basel)
. 2024 Jan;
16(2).
PMID: 38254847
Multiple myeloma is a hematologic neoplasm caused by abnormal proliferation of plasma cells. Sequencing studies suggest that plasma cell disorders are caused by both cytogenetic abnormalities and oncogene mutations. Therefore,...
4.
Popescu B, Stahlhut C, Tarver T, Wishner S, Lee B, Peretz C, et al.
Cell Rep Med
. 2023 Nov;
4(11):101290.
PMID: 37992684
Mutations in the receptor tyrosine kinases (RTKs) FLT3 and KIT are frequent and associated with poor outcomes in acute myeloid leukemia (AML). Although selective FLT3 inhibitors (FLT3i) are clinically effective,...
5.
Wilkins J, Gakh O, Guo Y, Popescu B, Staff N, Lucchinetti C
Front Cell Neurosci
. 2023 Sep;
17:1223912.
PMID: 37744877
Multiple sclerosis (MS) is the leading cause of non-traumatic disability in young adults. New avenues are needed to help predict individuals at risk for developing MS and aid in diagnosis,...
6.
Cirstea A, Bertesteanu S, Scaunasu R, Popescu B, Bejenaru P, Simion-Antonie C, et al.
Int J Environ Res Public Health
. 2023 Mar;
20(6).
PMID: 36981644
Laryngeal cancer is an important oncological entity in which prognosis depends on the establishment of appropriate preventive and diagnostic measures, especially in high-risk populations. We present a retrospective two-year study...
7.
Popescu B, Shannon K
J Exp Med
. 2023 Mar;
220(5).
PMID: 36880733
Allosteric SHP2 inhibitors are a novel class of compounds that target hyperactive Ras/Mitogen Activated Protein Kinase (MAPK) signaling. In this issue of JEM, Wei et al. (2023. J. Exp. Med.https://doi.org/10.1084/jem.20221563)...
8.
Pariury H, Fandel J, Bachl S, Ang K, Markossian S, Wilson C, et al.
Haematologica
. 2023 Jan;
108(5):1272-1283.
PMID: 36700399
Hypodiploid acute lymphoblastic leukemia (ALL) is an aggressive blood cancer with a poor prognosis despite intensive chemotherapy or stem cell transplant. Children and adolescents with positive end-of-induction minimal residual disease...
9.
Sofronie M, Popescu B, Enculescu M, Tolea M, Tolea F
Nanomaterials (Basel)
. 2022 Oct;
12(20).
PMID: 36296857
The influence of processing on the martensitic transformation and related magnetic properties of the NiFeNdGa ferromagnetic shape memory alloy, as bulk and ribbons prepared by the melt spinning method and...
10.
Bejenaru P, Popescu B, Oancea A, Simion-Antonie C, Bertesteanu G, Condeescu-Cojocarita M, et al.
J Clin Med
. 2022 Aug;
11(16).
PMID: 36013113
Squamous cell carcinoma of the head and neck (HNSCC) is a common malignancy often diagnosed in the advanced stage with a complex negative influence on the patient's quality of life...